Immunology - First Aid Flashcards

1
Q

1° Immune System Organs

A
  • Bone Marrow
  • Thymus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2° Immune System Organs

A
  • Spleen
  • Lymph Nodes
  • Tonsils
  • Peyer Patches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immune System Organs:

  • immune cell production
  • B cell maturation
A

Bone Marrow

Bone Marrow = B Cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Immune System Organs:

T cell maturation

A

Thymus

Thymus = T Cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Immune System Organs:

allow immune cells to interact with antigen

A

2° organs:

  • Spleen
  • Lymph Nodes
  • Tonsils
  • Peyer Patches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Immune System Organs:

  • 2° lymphoid organ that has many afferents, 1 or more efferents
  • encapsulated, with trabeculae
  • functions are nonspecific filtration by macrophages, storage of B and T cells, and immune response activation
A

Lymph Node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lymph Node

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lymph Node:

  • site of B-cell localization and proliferation
  • outer cortex
A

Follicle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lymph Node:

  • dense
  • dormant
A

1° follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lymph Node:

  • have pale central germinal centers
  • active
A

2° follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lymph Node:

  • consists of cords (closely packed lymphocytes and plasma cells) and sinuses
  • sinuses communicate with efferent lymphatics and contain reticular cells and macrophages
A

Medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lymph Node:

  • houses T cells.
  • region of cortex between follicles and medulla
  • contains high endothelial venules through which T and B cells enter from blood
  • not well developed in patients with DiGeorge syndrome
  • enlarges in an extreme cellular immune response (eg. viral infection)
A

Paracortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lymphatic Drainage Associations

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lymphatic Drainage Associations:

drains head and neck

A

Cervical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lymphatic Drainage Associations:

  • URTI
  • Infectious Mononucleosis
  • Kawasaki disease
A

Cervical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lymphatic Drainage Associations:

drains trachea and esophagus

A

Mediastinal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Lymphatic Drainage Associations:

  • 1° Lung Cancer
  • Granulomatous disease
A

Mediastinal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lymphatic Drainage Associations:

drains lungs

A

Hilar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lymphatic Drainage Associations:

Granulomatous disease

A

Hilar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lymphatic Drainage Associations:

drains upper limbs, breast, and skin above umbilicus

A

Axillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Lymphatic Drainage Associations:

  • Mastitis
  • Metastasis (especially breast cancer)
A

Axillary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lymphatic Drainage Associations:

drains liver, stomach, spleen, pancreas, and upper duodenum

A

Celiac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Lymphatic Drainage Associations:

drains lower duodenum, jejunum, ileum, and colon to splenic flexure

A

Superior Mesenteric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Lymphatic Drainage Associations:

drains colon from splenic flexure to upper rectum

A

Inferior Mesenteric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Lymphatic Drainage Associations:

  • Mesenteric Lymphadenitis
  • Typhoid Fever
  • Ulcerative Colitis
  • Celiac disease
A
  • Celiac
  • Superior Mesenteric
  • Inferior Mesenteric
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Lymphatic Drainage Associations:

drains testes, ovaries, kidneys, and uterus

A

Para-aortic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Lymphatic Drainage Associations:

Metastasis

A

Para-aortic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Lymphatic Drainage Associations:

drains lower rectum to anal canal (above pectinate line), bladder, vagina (middle third), cervix, and prostate

A

Internal Iliac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Lymphatic Drainage Associations:

drains anal canal (below pectinate line), skin below umbilicus (except popliteal area), scrotum, and vulva

A

Superficial Inguinal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Lymphatic Drainage Associations:

Sexually Transmitted Infections

A
  • Internal Iliac
  • Superficial Inguinal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Lymphatic Drainage Associations:

drains dorsolateral foot and posterior calf

A

Popliteal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Lymphatic Drainage Associations:

Foot/Leg Cellulitis

A

Popliteal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

The right lymphatic duct drains the right side of body above diaphragm into the _____.

A

junction of the right subclavian and internal jugular vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

The _____ drains everything into the junction of left subclavian and internal jugular veins. Rupture can cause chylothorax.

A

Thoracic Duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

The spleen is located in the _____ and is protected by _____.

A

LUQ of abdomen, anterior to left kidney

ribs 9-11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Spleen

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Spleen:
long, vascular channels in red pulp with fenestrated “barrel hoop” basement membrane

A

Sinusoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Spleen:

T cells are found in the _____ within the white pulp.

A

Periarteriolar Lymphatic Sheath (PALS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Spleen:

B cells are found in _____ within the white pulp.

A

follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Spleen:

  • in between the red pulp and white pulp
  • contains macrophages and specialized B cells
  • where antigen-presenting cells (APCs) capture blood-borne antigens for recognition by lymphocytes
A

Marginal Zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Splenic macrophages remove _____ bacteria.

A

encapsulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Splenic Dysfunction

A

↓ IgM → ↓ complement activation → ↓ C3b opsonization → ↑ susceptibility to encapsulated organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Postsplenectomy Blood Findings

A
  • Howell-Jolly bodies (nuclear remnants)
  • Target cells
  • Thrombocytosis (loss of sequestration and removal)
  • Lymphocytosis (loss of sequestration)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

You should vaccinate patients undergoing splenectomy against _____.

A

encapsulated organisms

  • pneumococcal
  • Hib
  • meningococcal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

The thymus is located in the _____.

A

anterosuperior mediastinum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

The _____ is an encapsulated organ where T-cells differentiate and mature.

A

Thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

The thymus is derived from the _____.

A

3rd pharyngeal pouch

Thymus = Third pharyngeal pouch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

The thymus contains lymphocytes of _____ origin.

A

mesenchymal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Thymus:

dense with immature T cells

A

Cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Thymus:

  • pale
  • mature T cells
  • Hassall corpuscles containing epithelial reticular cells
A

Medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

The normal neonatal thymus is _____ on CXR, involutes with age.

A

“sail-shaped”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

The thymus is hypoplastic in _____.

A
  • DiGeorge Syndrome
  • Severe Combined Immunodeficiency (SCID)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

_____ is a neoplasm of thymus. It is associated with myasthenia gravis and superior vena cava syndrome.

A

Thymoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Innate Immunity:

Components

A
  • neutrophils
  • macrophages
  • monocytes
  • dendritic cell
  • natural killer (NK) cells (lymphoid origin),
  • complement
  • physical epithelial barriers
  • secreted enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Innate Immunity:

Mechanism

A

germline encoded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Innate Immunity:

Resistance

A
  • resistance persists through generations
  • does not change within an organism’s lifetime
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Innate Immunity:

Response to Pathogens

A
  • nonspecific
  • occurs rapidly (minutes to hours)
  • no memory response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Innate Immunity:

Secreted Proteins

A
  • lysozyme
  • complement
  • C-reactive protein (CRP)
  • defensins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Innate Immunity:

Pathogen Recognition

A
  • Toll-like receptors (TLRs): pattern recognition receptors that recognize pathogen-associated molecular patterns (PAMPs) and lead to activation of NF-κB
  • Examples of PAMPs include LPS (gram ⊝ bacteria), flagellin (bacteria), nucleic acids (viruses).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Adaptive Immunity:

Components

A
  • T cells
  • B cells
  • circulating antibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Adaptive Immunity:

Mechanism

A

variation through V(D)J recombination during lymphocyte development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Adaptive Immunity:

Resistance

A

microbial resistance not heritable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Adaptive Immunity:

Response to Pathogens

A
  • highly specific
  • refined over time
  • develops over long periods
  • memory response is faster and more robust
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Adaptive Immunity:

Secreted Proteins

A

immunoglobulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Adaptive Immunity:

Pathogen Recognition

A
  • Memory cells: activated B and T cells
  • Subsequent exposure to a previously encountered antigen → stronger, quicker immune response.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Major histocompatibility complex I and II are encoded by _____.

A

HLA genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

_____ present antigen fragments to T cells and bind T-cell receptors (TCRs).

A

Major Histocompatibility Complex I and II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

MHC I:

Loci

A
  • HLA-A
  • HLA-B
  • HLA-C

MHC I loci have 1 letter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

MHC I:

Binding

A
  • TCR
  • CD8
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

MHC I:

Structure

A

1 long chain, 1 short chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

MHC I:

Expression

A
  • all nucleated cells, APCs, platelets
  • not on RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

MHC I:

Function

A

present endogenously synthesized antigens (eg. viral or cytosolic proteins) to CD8+ cytotoxic T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

MHC I:

Antigen Loading

A

antigen peptides loaded onto MHC I in RER after delivery via TAP (transporter associated with antigen processing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

MHC I:

Associated Protein

A

β2-microglobulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

MHC II:

Loci

A
  • HLA-DP
  • HLA-DQ
  • HLA-DR

MHC II loci have 2 letters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

MHC II:

Binding

A
  • TCR
  • CD4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

MHC II:

Structure

A

2 equal-length chains (2 α, 2 β)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

MHC II:

Expression

A

APCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

MHC II:

Function

A

present exogenously synthesized antigens (eg. bacterial proteins) to CD4+ helper T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

MHC II:

Antigen Loading

A

antigen loaded following release of invariant chain in an acidified endosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

MHC II:

Associated Protein

A

invariant chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

HLA Subtypes:

Hemochromatosis

A

A3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

HLA Subtypes:

  • Addison disease
  • Myasthenia Gravis
  • Graves disease
A

B8

Don’t Be late(8), Dr. Addison, or else you’ll send my patient to the grave.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

HLA Subtypes:

  • Psoriatic Arthritis
  • Ankylosing Spondylitis,
  • IBD-associated Arthritis
  • Reactive Arthritis
A

B27

PAIR

*also known as seronegative arthropathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

HLA Subtypes:

Celiac disease

A

DQ2/DQ8

I ate (8) too (2) much gluten at Dairy Queen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

HLA Subtypes:

  • Multiple Sclerosis
  • Hay Fever
  • SLE
  • Goodpasture Syndrome
A

DR2

Multiple hay pastures have dirt.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

HLA Subtypes:

  • Diabetes Mellitus Type 1
  • SLE
  • Graves disease,
  • Hashimoto Thyroiditis
  • Addison disease
A

DR3

2-3, S-L-E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

HLA Subtypes:

  • Rheumatoid Arthritis
  • Diabetes Mellitus Type 1
  • Addison disease
A

DR4

There are 4 walls in a “rheum” (room).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

HLA Subtypes:

Hashimoto Thyroiditis

A

DR5

Hashimoto is an odd doctor (DR3, DR5).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Natural killer cells are lymphocyte members of the _____.

A

innate immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Natural killer cells use _____ to induce apoptosis of virally infected cells and tumor cells.

A
  • perforin
  • granzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Natural killer cells’ activity is enhanced by _____.

A
  • IL-2
  • IL-12
  • IFN-α
  • IFN-β
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

_____ are induced to kill when exposed to a nonspecific activation signal on target cell and/or to an absence of MHC I on target cell surface.

A

Natural Killer Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Natural killer cells kill via _____ (CD16 binds Fc region of bound Ig, activating the NK cell).

A

antibody-dependent cell-mediated cytotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Immune Cells:

  • humoral immunity
  • recognize antigen—undergo somatic hypermutation to optimize antigen specificity
  • produce antibody—differentiate into plasma cells to secrete specific immunoglobulins.
  • maintain immunologic memory—memory _____ persist and accelerate future response to antigen.
A

B Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Immune Cells:

  • cell-mediated immunity
  • CD4+ _____ help B cells make antibodies and produce cytokines to recruit phagocytes and activate other leukocytes
  • CD8+ _____ directly kill virus-infected cells
  • delayed cell-mediated hypersensitivity (type IV)
  • acute and chronic cellular organ rejection
A

T Cells

Rule of 8:

  • MHC II × CD4 = 8
  • MHC I × CD8 = 8
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Differentiation of T Cells

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Differentiation of T Cells:

  • thymic cortex
  • T cells expressing TCRs capable of binding self-MHC on cortical epithelial cells survive
A

Positive Selection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Differentiation of T Cells:

  • thymic medulla
  • T cells expressing TCRs with high affinity for self antigens undergo apoptosis or become regulatory T cells
  • tissue-restricted self-antigens are expressed in the thymus due to the action of autoimmune regulator (AIRE)—deficiency leads to autoimmune polyendocrine syndrome-1
A

Negative Selection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Th1 cells secrete _____.

A

IFN-γ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

_____ activate macrophages and cytotoxic T cells to kill phagocytosed microbes.

A

Th1 Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Th1 cells are induced by _____.

A
  • IFN-γ
  • IL-12
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Th1 cells are inhibited by _____.

A
  • IL-4
  • IL-10

*from Th2 cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Th1 Cells:

Immunodeficiency

A

Mendelian Susceptibility to Mycobacterial Disease (MSMD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Th2 cells secrete _____.

A
  • IL-4
  • IL-5
  • IL-6
  • IL-10
  • IL-13
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

_____ activate eosinophils and promote production of IgE for parasite defense.

A

Th2 Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Th2 cells are induced by _____.

A
  • IL-2
  • IL-4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Th2 cells are inhibited by _____.

A

IFN-γ

*from Th1 cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Th17 cells secrete _____.

A
  • IL-17
  • IL-21
  • IL-22
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

_____ provide immunity against extracellular microbes, through induction of neutrophilic inflammation.

A

Th17 Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Th17 cells are induced by _____.

A
  • TGF-β
  • IL-1
  • IL-6
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Th17 cells are inhibited by _____.

A
  • IFN-γ
  • IL-4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Th17 Cells:

Immunodeficiency

A

Hyper-IgE Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Treg cells secrete _____.

A
  • TGF-β
  • IL-10
  • IL-35
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

_____ prevent autoimmunity by maintaining tolerance to self-antigens.

A

Treg Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Treg cells are induced by _____.

A
  • TGF-β
  • IL-2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Treg cells are inhibited by _____.

A

IL-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Treg Cells:

Immunodeficiency

A

IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Immunity:

  • Th1 cells secrete IFN-γ, which enhances the ability of monocytes and macrophages to kill microbes they ingest.
  • This function is also enhanced by interaction of T cell CD40L with CD40 on macrophages.
A

Macrophage-Lymphocyte Interaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Immunity:

  • kill virus-infected, neoplastic, and donor graft cells by inducing apoptosis
  • release cytotoxic granules containing preformed proteins (eg. perforin, granzyme B)
  • have CD8, which binds to MHC I on virus-infected cells
A

Cytotoxic T Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Immunity:

  • help maintain specific immune tolerance by suppressing CD4 and CD8 T-cell effector functions
  • identified by expression of CD3, CD4, CD25, and FOXP3
  • once activated, they produce anti-inflammatory cytokines (eg. IL-10, TGF-β)
A

Regulatory T Cells (Tregs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

_____ is caused by the genetic deficiency of FOXP3 → autoimmunity. Characterized by enteropathy, endocrinopathy, nail dystrophy, dermatitis, and/or other autoimmune dermatologic conditions. Associated with diabetes in male infants.

A

IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

Antigen-Presenting Cells

A
  • B Cells
  • Dendritic Cells
  • Langerhans Cells
  • Macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

T Cell Activation

A
  1. Dendritic cell (specialized APC) samples antigen, processes antigen, and migrates to the draining lymph node.
  2. T-cell activation (signal 1): antigen ispresented on MHC II and recognized by TCR on Th (CD4+) cell. Endogenous or cross-presented antigen is presented on MHC I to Tc (CD8+) cell.
  3. Proliferation and survival (signal 2): costimulatory signal via interaction of B7 protein (CD80/86) on dendritic cell and CD28 on naïve T cell.
  4. Th cell activates and produces cytokines. Tc cell activates and is able to recognize and kill virus-infected cell.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

B Cell Activation

A
  1. Th-cell activation as above.
  2. B-cell receptor–mediated endocytosis; foreign antigen is presented on MHC II and recognized by TCR on Th cell.
  3. CD40 receptor on B cell binds CD40 ligand (CD40L) on Th cell.
  4. Th cell secretes cytokines that determine Ig class switching of B cell. B cell activates and undergoes class switching, affinity maturation, and antibody production.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

Antibody Structure

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

Antibody Function

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

Antibodies:

_____ (containing the variable/hypervariable regions) consisting of light (L) and heavy (H) chains recognizes antigens.

A

Fab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

Antibodies:

_____ of IgM and IgG fixes complement.

A

Fc region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

Antibodies:

_____ contributes to Fc and Fab regions.

A

Heavy Chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

Antibodies:

_____ contributes only to Fab region.

A

Light Chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

Antibodies:

  • fragment, antigen binding
  • determines idiotype: unique antigen-binding pocket; only 1 antigenic specificity expressed per B cell
A

Fab

Fragment, antigen binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

Antibodies:

  • constant
  • carboxy terminal
  • complement binding
  • carbohydrate side chains
  • determines isotype (IgM, IgD, etc)
A

Fc

  • constant
  • carboxy terminal
  • complement binding
  • carbohydrate side chains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

Generation of Antibody Diversity

(antigen independent)

A
  1. random recombination of VJ (light-chain) or V(D)J (heavy-chain) genes
  2. random addition of nucleotides to DNA during recombination by terminal deoxynucleotidyl transferase (TdT)
  3. random combination of heavy chains with light chains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

Generation of Antibody Specificity

(antigen dependent)

A
  1. somatic hypermutation and affinity maturation (variable region)
  2. isotype switching (constant region)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

All immunoglobulin isotypes can exist as _____.

A

monomers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

Mature, naive B cells prior to activation express _____ on their surfaces.

A
  • IgM
  • IgD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

Mature, naive B cells may differentiate in germinal centers of lymph nodes by isotype switching (gene rearrangement; induced by cytokines and CD40L) into plasma cells that secrete _____.

A
  • IgA
  • IgE
  • IgG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

Immunoglobulin Isotypes:

  • main antibody in 2° response to an antigen
  • most abundant isotype in serum
  • fixes complement, opsonizes bacteria, neutralizes bacterial toxins an viruses
  • only isotype that crosses the placenta (provides infants with passive immunity)
A

IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Immunoglobulin Isotypes:

  • prevents attachment of bacteria and viruses to mucous membranes; does not fix complement
  • monomer (in circulation) or dimer (with J chain when secreted)
  • crosses epithelial cells by transcytosis
  • produced in GI tract (eg. by Peyer patches) and protects against gut infections (eg. Giardia)
  • most produced antibody overall, but has lower serum concentrations
  • released into secretions (tears, saliva, mucus) and breast milk
  • picks up secretory component from epithelial cells, which protects the Fc portion from luminal proteases
A

IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

Immunoglobulin Isotypes:

  • produced in the 1° (immediate) response to an antigen
  • fixes complement
  • cannot cross the placenta
  • antigen receptor on the surface of B cells
  • monomer on B cell, pentamer with J chain when secreted
  • pentamer enables avid binding to antigen while humoral response evolves
A

IgM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

Immunoglobulin Isotypes:

  • unclear function
  • found on surface of many B cells and in serum
A

IgD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

Immunoglobulin Isotypes:

  • binds mast cells and basophils; cross-links when exposed to allergen, mediating immediate (type I) hypersensitivity through release of inflammatory mediators such as histamine
  • contributes to immunity to parasites by activating eosinophils
  • lowest concentration in serum
A

IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

Antigen Type and Memory:

  • antigens lacking a peptide component (eg. lipopolysaccharides from gram ⊝ bacteria)
  • cannot be presented by MHC to T cells
  • weakly immunogenic
  • vaccines often require boosters and adjuvants (eg. pneumococcal polysaccharide vaccine)
A

Thymus-Independent Antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

Antigen Type and Memory:

  • antigens containing a protein component (eg. diphtheria vaccine)
  • class switching and immunologic memory occur as a result of direct contact of B cells with Th cells
A

Thymus-Dependent Antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

_____ is a system of hepatically synthesized plasma proteins that play a role in innate immunity and inflammation.

A

Complement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

Membrane Attack Complex (MAC) defends against _____.

A

gram ⊝ bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

Complement Activation Pathways:

IgG or IgM mediated

A

Classic

GM makes classic cars.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

Complement Activation Pathways:

microbe surface molecules

A

Alternative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

Complement Activation Pathways:

mannose or other sugars on microbe surface

A

Lectin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

Complement Activation Pathways

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

Complement Functions:

opsonization

A

C3b

C3b binds bacteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

Complement Functions:

anaphylaxis

A
  • C3a
  • C4a
  • C5a

C3a, C4a, C5a = anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

Complement Functions:

neutrophil chemotaxis

A

C5a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

Complement Functions:

cytolysis by MAC

A

C5b-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

C3b and IgG are the two 1° _____ in bacterial defense; enhance phagocytosis. C3b also helps clear immune complexes.

A

Opsonins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

_____ like decay-accelerating factor (DAF, aka CD55) and C1 esterase inhibitor help prevent complement activation on self cells (eg. RBCs).

A

Inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

Complement Protein Peficiencies

A
  • Early Complement Deficiencies (C1-C4)
  • Terminal Complement Deficiencies (C5–C9)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

Complement Disorders:

  • increased risk of severe, recurrent pyogenic sinus and respiratory tract infections
  • increased risk of SLE
A

Early Complement Deficiencies (C1-C4)

160
Q

Complement Disorders:

increased susceptibility to recurrent Neisseria bacteremia

A

Terminal Complement Deficiencies (C5–C9)

161
Q

Complement Regulatory Protein Deficiencies

A
  • C1 Esterase Inhibitor Deficiency
  • Paroxysmal Nocturnal Hemoglobinuria
162
Q

Complement Disorders:

  • causes hereditary angioedema due to unregulated activation of kallikrein → ↑ bradykinin
  • characterized by ↓ C4 levels
  • ACE inhibitors are contraindicated
A

C1 Esterase Inhibitor Deficiency

163
Q

Complement Disorders:

  • a defect in the PIGA gene preventing the formation of anchors for complement inhibitors, such as decay-acclerating factor (DAF/CD55) and membrane inhibitor of reactive lysis (MIRL/CD59)
  • causes complement-mediated lysis of RBCs
A

Paroxysmal Nocturnal Hemoglobinuria

164
Q

Interleukins

A

Hot T-bone stEAK”:

  • IL-1: fever (hot)
  • IL-2: stimulates T cells
  • IL-3: stimulates bone marrow
  • IL-4: stimulates IgE production
  • IL-5: stimulates IgA production
  • IL-6: stimulates aKute-phase protein production
165
Q

Cytokines Secreted by Macrophages

A
  • Interleukin-1
  • Interleukin-6
  • Interleukin-8
  • Interleukin-12
  • Tumor Necrosis Factor-α
166
Q

Cytokines Secreted by Macrophages:

  • causes fever, acute inflammation
  • activates endothelium to express adhesion molecules
  • induces chemokine secretion to recruit WBCs
  • also known as osteoclast-activating factor
A

Interleukin-1

167
Q

Cytokines Secreted by Macrophages:

  • causes fever
  • stimulates production of acutephase proteins
A

Interleukin-6

168
Q

Cytokines Secreted by Macrophages:

major chemotactic factor for neutrophils

A

Interleukin-8

Clean up on aisle 8.”

Neutrophils are recruite by IL-8 to clear infections.

169
Q

Cytokines Secreted by Macrophages:

  • induces differentiation of T cells into Th1 cells
  • activates NK cells
A

Interleukin-12

170
Q

Cytokines Secreted by Macrophages:

  • activates endothelium
  • causes WBC recruitment, vascular leak
  • causes cachexia in malignancy
  • maintains granulomas in TB
A

Tumor Necrosis Factor-α

171
Q

_____ are cytokines that can mediate fever and sepsis.

A
  • IL-1
  • IL-6
  • TNF-α
172
Q

Cytokines Secreted by All T Cells

A
  • Interleukin-2
  • Interleukin-3
173
Q

Cytokines Secreted by All T Cells:

stimulates growth of helper, cytotoxic, and regulatory T cells, and NK cells

A

Interleukin-2

174
Q

Cytokines Secreted by All T Cells:

  • supports growth and differentiation of bone marrow stem cells
  • functions like GM-CSF
A

Interleukin-3

175
Q

Cytokines from Th1 Cells

A

Interferon-γ

176
Q

Cytokines from Th1 Cells:

  • secreted by NK cells and T cells in response to antigen or IL-12 from macrophages
  • stimulates macrophages to kill phagocytosed pathogens
  • inhibits differentiation of Th2 cells
  • activates NK cells to kill virus-infected cells
  • increases MHC expression and antigen presentation by all cells
A

Interferon-γ

177
Q

Cytokines from Th2 Cells

A
  • Interleukin-4
  • Interleukin-5
  • Interleukin-10
178
Q

Cytokines from Th2 Cells:

  • induces differentiation of T cells into Th (helper) 2 cells
  • promotes growth of B cells
  • enhances class switching to IgE and IgG
A

Interleukin-4

Ain’t too proud 2 BEG 4 help.

179
Q

Cytokines from Th2 Cells:

  • promotes growth and differentiation of B cells
  • enhances class switching to IgA
  • stimulates growth and differentiation of eosinophils
A

Interleukin-5

180
Q

Cytokines from Th2 Cells:

  • attenuates inflammatory response
  • decreases expression of MHC class II and Th1 cytokines
  • inhibits activated macrophages and dendritic cells
  • also secreted by regulatory T cells
A

Interleukin-10

TGF-β and IL-10 both attenuate the immune response.

181
Q

Immunity:

  • involves the activation of the phagocyte NADPH oxidase complex (eg. in neutrophils, monocytes), which utilizes O2 as a substrate
  • plays an important role in the immune response → rapid release of reactive oxygen species (ROS)
  • NADPH plays a role in both the creation and neutralization
A

Respiratory Burst

(Oxidative Burst)

182
Q

_____ contains a blue-green heme-containing pigment that gives sputum its color.

A

Myeloperoxidase

183
Q

Respiratory Burst

(Oxidative Burst)

A
184
Q

Phagocytes of patients with _____ can utilize H2O2 generated by invading organisms and convert it to ROS. Patients are at ↑ risk for infection by catalase ⊕ species (eg. S. aureus, Aspergillus) capable of neutralizing their own H2O2, leaving phagocytes without ROS for fighting infections.

A

Chronic Granulomatous Disease

185
Q

_____ of P. aeruginosa generates ROS to kill competing pathogens.

A

Pyocyanin

186
Q

Oxidative burst leads to _____, which releases lysosomal enzymes from proteoglycans.

A

K+ influx

187
Q

_____ is a protein found in secretory fluids and neutrophils that inhibits microbial growth via iron chelation.

A

Lactoferrin

188
Q

Immunity:

  • part of innate host defense against both RNA and DNA viruses
  • glycoproteins synthesized by virus-infected cells that act on local cells, “priming them” for viral defense by downregulating protein synthesis to resist potential viral replication and upregulating MHC expression to facilitate recognition of infected cells
A

Interferon-α and -β

Interfere with viruses.

189
Q

Cell Surface Proteins:

T Cells

A
  • TCR (binds antigen-MHC complex)
  • CD3 (associated with TCR for signal transduction)
  • CD28 (binds B7 on APC)
190
Q

Cell Surface Proteins:

Helper T Cells

A
  • CD4
  • CD40L
  • CXCR4/CCR5 (co-receptor for HIV)
191
Q

Cell Surface Proteins:

Cytotoxic T Cells

A

CD8

192
Q

Cell Surface Proteins:

Regulatory T Cells

A
  • CD4
  • CD25
193
Q

Cell Surface Proteins:

B Cells

A
  • Ig (binds antigen)
  • CD19
  • CD20
  • CD21 (receptor for EBV)
  • CD40
  • MHC II
  • B7

You can drink Beer at the Bar when you’re 21: B cells, Epstein-Barr virus, CD21.

194
Q

Cell Surface Proteins:

Macrophages

A
  • CD14 (receptor for PAMPs, eg. LPS)
  • CD40
  • CCR5
  • MHC II
  • B7 (CD80/86)
  • Fc and C3b receptors (enhanced phagocytosis)
195
Q

Cell Surface Proteins:

NK Cells

A
  • CD16
  • CD56 (suggestive marker for NK)
196
Q

Cell Surface Proteins:

Hematopoietic Stem Cells

A

CD34

197
Q

_____ is the state during which a cell cannot become activated by exposure to its antigen. This seen in T and B cells when exposed to their antigen without costimulatory signal (signal 2). Another mechanism of self-tolerance.

A

Anergy

198
Q

Immunity:

  • receiving preformed antibodies
  • rapid onset
  • short span of antibodies (half-life = 3 weeks)
A

Passive

199
Q

Immunity:

  • IgA in breast milk
  • maternal IgG crossing placenta
  • antitoxin
  • humanized monoclonal antibody
A

Passive

200
Q

Immunity:

  • exposure to foreign antigens
  • slow onset
  • long-lasting protection (memory)
A

Active

201
Q

Immunity:

  • natural infection
  • vaccines
  • toxoid
A

Active

202
Q

After exposure to _____, unvaccinated patients are given preformed antibodies (passive).

A

Diseases To Be Healed Very Rapidly”

  • Diphtheria toxin
  • Tetanus toxin
  • Botulinum toxin
  • HBV
  • Varicella
  • Rabies virus
203
Q

Combined passive and active immunizations can be given for _____ exposure.

A
  • Hepatitis B
  • Rabies
204
Q

Vaccines:

  • microorganism loses its pathogenicity but retains capacity for transient growth within inoculated host
  • induces cellular and humoral responses
A

Live Attenuated Vaccine

205
Q

_____ vaccines can be given to HIV ⊕ patients without evidence of immunity if CD4 cell count ≥ 200 cells/mm3.

A
  • MMR
  • Varicella
206
Q

Vaccines:

Pros of Live Attenuated Vaccine

A

induces strong, often lifelong immunity

207
Q

Vaccines:

Cons of Live Attenuated Vaccine

A
  • may revert to virulent form
  • often contraindicated in pregnancy and immunodeficiency
208
Q

Live Attenuated Vaccines

A

Attention! Please Vaccinate Small, Beautiful Young Infants with MMR Regularly!”

  • Adenovirus (nonattenuated, given to military recruits)
  • Polio (Sabin)
  • Varicella (chickenpox)
  • Smallpox
  • BCG
  • Yellow fever
  • Influenza (intranasal)
  • MMR
  • Rotavirus
209
Q

Vaccines:

  • pathogen is inactivated by heat or chemicals
  • maintaining epitope structure on surface antigens is important for immune response
  • mainly induces a humoral response
A

Killed or Inactivated Vaccine

210
Q

Vaccines:

Pros of Killed or Inactivated Vaccine

A

safer than live vaccines

211
Q

Vaccines:

Cons of Killed or Inactivated Vaccine

A
  • weaker immune response
  • booster shots usually required
212
Q

Killed or Inactivated Vaccines

A

RIP Always

  • Rabies
  • Influenza (injection)
  • Polio (Salk)—SalK = Killed
  • Hepatitis A
213
Q

Vaccines:

includes only the antigens that best stimulate the immune system

A

Subunit Vaccine

214
Q

Vaccines:

Pros of Subunit Vaccine

A

lower chance of adverse reactions

215
Q

Vaccines:

Cons of Subunit Vaccine

A
  • expensive
  • weaker immune response
216
Q

Subunit Vaccines

A
  • HBV (antigen = HBsAg)
  • HPV (types 6, 11, 16, and 18)
  • acellular Pertussis (aP)
  • Neisseria meningitidis (various strains)
  • Streptococcus pneumoniae
  • Haemophilus influenzae type b
217
Q

Vaccines:

  • denatured bacterial toxin with an intact receptor binding site
  • stimulates the immune system to make antibodies without potential for causing disease
A

Toxoid

218
Q

Vaccines:

Pros of Toxoid

A

protects against the bacterial toxins

219
Q

Vaccines:

Cons of Toxoid

A
  • antitoxin levels decrease with time
  • may require a booster
220
Q

Toxoids

A
  • Clostridium tetani
  • Corynebacterium diphtheriae
221
Q

Hypersensitivity Types

A

ABCD

  • Anaphylactic and Atopic (type I)
  • AntiBody-mediated (type II)
  • Immune Complex (type III)
  • Delayed (cell-mediated, type IV)

*Types I, II, and III are all antibody-mediated.

222
Q

Type I Hypersensitivity

Anaphylactic and Atopic

A
  • Immediate (minutes): antigen crosslinks preformed IgE on presensitized mast cells → immediate degranulation → release of histamine (a vasoactive amine) and tryptase (a marker of mast cell activation).
  • Late (hours): chemokines (attract inflammatory cells, eg. eosinophils) and cytokines (eg. leukotrienes) from mast cells → inflammation and tissue damage.

First (type) and Fast (anaphylaxis).

223
Q

Tests for Type I Hypersensitivity

A

skin test or blood test (ELISA) for allergen-specific IgE

224
Q

Type II Hypersensitivity

Antibody-Mediated

A
  • Antibodies bind to cell-surface antigens → cellular destruction, inflammation, and cellular dysfunction.
  • Cellular Destruction—cell is opsonized (coated) by antibodies, leading to either:
    • Phagocytosis and/or activation of complement system.
    • NK cell killing (antibody-dependent cellular cytotoxicity).
  • Inflammation—binding of antibodies to cell surfaces → activation of complement system and Fc receptor-mediated inflammation.
  • Cellular Dysfunction—antibodies bind to cell surface receptors → abnormal blockade or activation of downstream process.
225
Q

Tests for Type II Hypersensitivity

A
  • Direct Coombs test—detects antibodies attached directly to the RBC surface.
  • Indirect Coombs test—detects presence of unbound antibodies in the serum
226
Q

Examples of Type II Hypersensitivity

A
  • Autoimmune Hemolytic Anemia
  • Immune Thrombocytopenia
  • Transfusion Reactions
  • Hemolytic Disease of the Newborn
  • Goodpasture Syndrome
  • Rheumatic Fever
  • Hyperacute Transplant Rejection
  • Myasthenia Gravis
  • Graves Disease
  • Pemphigus Vulgaris
227
Q

Type III Hypersensitivity

Immune Complex

A
  • Immune complex—antigen-antibody (mostly IgG) complexes activate complement, which attracts neutrophils; neutrophils release lysosomal enzymes.
  • Can be associated with vasculitis and systemic manifestations.

In type III reaction, imagine an immune complex as 3 things stuck together: antigen-antibody-complement.

228
Q

Hypersensitivity Reactions:

  • the prototype immune complex disease
  • antibodies to foreign proteins are produced and 1–2 weeks later, antibody-antigen complexes form and deposit in tissues → complement activation → inflammation and tissue damage
  • fever, urticaria, arthralgia, proteinuria, lymphadenopathy occur 1–2 weeks after antigen exposure
A

Serum Sickness

(Type III Hypersensitivity)

229
Q

Hypersensitivity Reactions:

  • a local subacute immune complex-mediated hypersensitivity reaction
  • intradermal injection of antigen into a presensitized (has circulating IgG) individual leads to immune complex formation in the skin
  • characterized by edema, necrosis, and activation of complement
A

Arthus Reaction

(Type III Hypersensitivity)

230
Q

Examples of Type III Hypersensitivity

A
  • SLE
  • Polyarteritis nodosa
  • Poststreptococcal glomerulonephritis
231
Q

Type IV Hypersensitivity

Delayed

A
  • Direct Cell Cytotoxicity: CD8+ cytotoxic T cells kill targeted cells.
  • Inflammatory Reaction: effector CD4+ T cell recognize antigen and release inflammation inducing cytokines (shown in illustration).

4T’s: T cells, Transplant rejections, TB skin tests, Touching (contact dermatitis).

Fourth (type) and last (delayed).

232
Q

Tests for Type IV Hypersensitivity

A
  • PPD (tuberculosis infection)
  • patch test (cause of contact dermatitis)
  • Candida extract (T cell immune function)
233
Q

Examples of Type IV Hypersensitivity

A
  • contact dermatitis (eg. poison ivy, nickel allergy)
  • graft-versus-host disease
234
Q

Blood Transfusion Reactions

A
  • Allergic/Anaphylactic Reaction
  • Febrile Nonhemolytic Transfusion Reaction
  • Acute Hemolytic Transfusion Reaction
  • Transfusion-Related Acute Lung Injury
235
Q

Blood Transfusion Reactions:

  • type I hypersensitivity reaction against plasma proteins in transfused blood
  • IgA deficient individuals must receive blood products without IgA
A

Allergic/Anaphylactic Reaction

236
Q

Blood Transfusion Reactions:

  • urticaria
  • pruritus
  • fever
  • wheezing
  • hypotension
  • respiratory arrest
  • shock
A

Allergic/Anaphylactic Reaction

237
Q

Blood Transfusion Reactions:

within minutes to 2–3 hours

A

Allergic/Anaphylactic Reaction

238
Q

Blood Transfusion Reactions:

  • type II hypersensitivity reaction with host antibodies against donor HLA and WBCs
  • induced by cytokines that are created and accumulate during the storage of blood products
A

Febrile Nonhemolytic Transfusion Reaction

239
Q

Blood Transfusion Reactions:

  • fever
  • headaches
  • chills
  • flushing
A

Febrile Nonhemolytic Transfusion Reaction

240
Q

Blood Transfusion Reactions:

within 1–6 hours

A

Febrile Nonhemolytic Transfusion Reaction

241
Q

Blood Transfusion Reactions:

  • type II hypersensitivity reaction
  • intravascular hemolysis (ABO blood group incompatibility)
  • extravascular hemolysis (host antibody reaction against foreign antigen on donor RBCs)
A

Acute Hemolytic Transfusion Reaction

242
Q

Blood Transfusion Reactions:

  • fever
  • hypotension
  • tachypnea
  • tachycardia
  • flank pain
  • hemoglobinuria (intravascular hemolysis)
  • jaundice (extravascular)
A

Acute Hemolytic Transfusion Reaction

243
Q

Blood Transfusion Reactions:

within 1 hour

A

Acute Hemolytic Transfusion Reaction

244
Q

Blood Transfusion Reactions:

donor anti-leukocyte antibodies against recipient neutrophils and pulmonary endothelial cells

A

Transfusion-Related Acute Lung Injury

245
Q

Blood Transfusion Reactions:

  • respiratory distress
  • noncardiogenic pulmonary edema
A

Transfusion-Related Acute Lung Injury

246
Q

Blood Transfusion Reactions:

within 6 hours

A

Transfusion-Related Acute Lung Injury

247
Q

Autoantibodies:

Myasthenia Gravis

A

Anti-ACh receptor

248
Q

Autoantibodies:

Lambert-Eaton Myasthenic Syndrome

A

Anti-Presynaptic Voltage-Gated Calcium Channel

249
Q

Autoantibodies:

Antiphospholipid Syndrome

A

Anti-β2 Glycoprotein

250
Q

Autoantibodies:

  • nonspecific screening antibody
  • often associated with SLE
A

Antinuclear (ANA)

251
Q

Autoantibodies:

  • SLE
  • Antiphospholipid Syndrome
A
  • Anticardiolipin
  • Lupus Anticoagulant
252
Q

Autoantibodies:

SLE

A
  • Anti-dsDNA
  • Anti-Smith
253
Q

Autoantibodies:

Drug-Induced Lupus

A

Anti-Histone

254
Q

Autoantibodies:

Mixed Connective Tissue Disease

A

Anti-U1 RNP (ribonucleoprotein)

255
Q

Autoantibodies:

Rheumatoid Arthritis

A
  • Rheumatoid Factor (IgM antibody against IgG Fc region)
  • Anti-CCP (more specific)
256
Q

Autoantibodies:

Sjögren Syndrome

A
  • Anti-Ro/SSA
  • Anti-La/SSB
257
Q

Autoantibodies:

Scleroderma (diffuse)

A

Anti-Scl-70 (anti-DNA topoisomerase I)

258
Q

Autoantibodies:

Limited Scleroderma (CREST syndrome)

A

Anticentromere

259
Q

Autoantibodies:

  • Polymyositis
  • Dermatomyositis
A
  • Antisynthetase (eg. anti-Jo-1)
  • Anti-SRP
  • Anti-Helicase (anti-Mi-2)
260
Q

Autoantibodies:

1° Biliary Cholangitis

A

Antimitochondrial Antibodies

261
Q

Autoantibodies:

Autoimmune Hepatitis Type 1

A

Anti-Smooth Muscle

262
Q

Autoantibodies:

  • Microscopic Polyangiitis
  • Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
  • Ulcerative Colitis
A

MPO-ANCA/p-ANCA

263
Q

Autoantibodies:

Granulomatosis with Polyangiitis (Wegener)

A

PR3-ANCA/c-ANCA

264
Q

Autoantibodies:

1° Membranous Nephropathy

A

Anti-Phospholipase A2 Receptor

265
Q

Autoantibodies:

Bullous Pemphigoid

A

Anti-Hemidesmosome

266
Q

Autoantibodies:

Pemphigus Vulgaris

A

Anti-Desmoglein (Anti-Desmosome)

267
Q

Autoantibodies:

Hashimoto Thyroiditis

A
  • Antimicrosomal
  • Antithyroglobulin
  • Antithyroid Peroxidase
268
Q

Autoantibodies:

Graves Disease

A

Anti-TSH Receptor

269
Q

Autoantibodies:

Celiac Disease

A
  • IgA Anti-Endomysial
  • IgA Anti-Tissue Transglutaminase
  • IgA and IgG Deamidated Gliadin Peptide
270
Q

Autoantibodies:

Type 1 Diabetes Mellitus

A
  • Anti-Glutamic Acid Decarboxylase
  • Islet Cell Cytoplasmic Antibodies
271
Q

Autoantibodies:

Pernicious Anemia

A
  • Antiparietal Cell
  • Anti-Intrinsic Factor
272
Q

Autoantibodies:

Goodpasture Syndrome

A

Anti-Glomerular Basement Membrane

273
Q

B-Cell Immunodeficiencies

A
  • X-linked (Bruton) Agammaglobulinemia
  • Selective IgA Deficiency
  • Common Variable Immunodeficiency
274
Q

B-Cell Immunodeficiencies:

  • defect in BTK, a tyrosine kinase gene → no B-cell maturation
  • X-linked recessive (↑ in boys)
A

X-linked (Bruton) Agammaglobulinemia

Bruton, BTK, B-cell, Boys

275
Q

B-Cell Immunodeficiencies:

recurrent bacterial and enteroviral infections after 6 months (↓ maternal IgG)

A

X-linked (Bruton) Agammaglobulinemia

276
Q

B-Cell Immunodeficiencies:

  • absent B cells in peripheral blood
  • ↓ Ig of all classes
  • absent/scanty lymph nodes and tonsils
  • live vaccines contraindicated
A

X-linked (Bruton) Agammaglobulinemia

277
Q

B-Cell Immunodeficiencies:

  • unknown defect
  • most common 1° immunodeficiency
A

Selective IgA Deficiency

278
Q

B-Cell Immunodeficiencies:

  • majority are asymptomatic
  • airway and GI infections
  • autoimmune disease
  • atopy
  • anaphylaxis to IgA-containing products
A

Selective IgA Deficiency

IgA, Asymptomatic, Airway, Autoimmune, Atopy, Anaphylaxis

279
Q

B-Cell Immunodeficiencies:

  • ↓ IgA with normal IgG, IgM levels
  • ↑ susceptibility to giardiasis
A

Selective IgA Deficiency

280
Q

B-Cell Immunodeficiencies:

  • defect in B-cell differentiation
  • cause is unknown in most cases
A

Common Variable Immunodeficiency

281
Q

B-Cell Immunodeficiencies:

  • usually presents after age 2 and may be considerably delayed
  • ↑ risk of autoimmune disease, bronchiectasis, lymphoma, and sinopulmonary infections
A

Common Variable Immunodeficiency

282
Q

B-Cell Immunodeficiencies:

  • ↑ plasma cells
  • ↑ immunoglobulins
A

Common Variable Immunodeficiency

283
Q

T-Cell Immunodeficiencies

A
  • Thymic Aplasia (DiGeorge Syndrome)
  • IL-12 Receptor Deficiency
  • Autosomal Dominant Hyper-IgE Syndrome (Job Syndrome)
  • Chronic Mucocutaneous Candidiasis
284
Q

T-Cell Immunodeficiencies:

  • 22q11 deletion
  • failure of 3rd and 4th pharyngeal pouches to develop → absent thymus and parathyroids
A

Thymic Aplasia (DiGeorge Syndrome)

285
Q

T-Cell Immunodeficiencies:

  • tetany (hypocalcemia)
  • recurrent viral/fungal infections (T-cell deficiency)
  • conotruncal abnormalities (eg. tetralogy of Fallot, truncus arteriosus)
A

Thymic Aplasia (DiGeorge Syndrome)

286
Q

T-Cell Immunodeficiencies:

  • ↓ T cells, ↓ PTH, ↓ Ca2+
  • thymic shadow absent on CXR
A

Thymic Aplasia (DiGeorge Syndrome)

287
Q

T-Cell Immunodeficiencies:

  • ↓ Th1 response
  • autosomal recessive
A

IL-12 Receptor Deficiency

288
Q

T-Cell Immunodeficiencies:

  • disseminated mycobacterial and fungal infections
  • may present after administration of BCG vaccine
A

IL-12 Receptor Deficiency

289
Q

T-Cell Immunodeficiencies:

↓ IFN-γ

A

IL-12 Receptor Deficiency

290
Q

T-Cell Immunodeficiencies:

deficiency of Th17 cells due to STAT3 mutation → impaired recruitment of neutrophils to sites of infection

A

Autosomal Dominant Hyper-IgE Syndrome (Job Syndrome)

291
Q

T-Cell Immunodeficiencies:

  • coarse facies
  • cold noninflamed staphylococcal abscesses
  • retained primary teeth
  • ↑ IgE
  • dermatologic problems (eczema)
  • bone fractures from minor trauma
A

Autosomal Dominant Hyper-IgE Syndrome (Job Syndrome)

FATED:

  • coarse Facies
  • cold (noninflamed) staphylococcal Abscesses
  • retained primary Teeth
  • ↑ IgE
  • Dermatologic problems (eczema)
292
Q

T-Cell Immunodeficiencies:

  • ↑ IgE
  • ↑ eosinophils
A

Autosomal Dominant Hyper-IgE Syndrome (Job Syndrome)

293
Q

T-Cell Immunodeficiencies:

  • T-cell dysfunction
  • can result from congenital genetic defects in IL-17 or IL-17 receptors
A

Chronic Mucocutaneous Candidiasis

294
Q

T-Cell Immunodeficiencies:
noninvasive Candida albicans infections of skin and mucous membranes

A

Chronic Mucocutaneous Candidiasis

295
Q

T-Cell Immunodeficiencies:

  • absent in vitro T-cell proliferation in response to Candida antigens
  • absent cutaneous reaction to Candida antigens
A

Chronic Mucocutaneous Candidiasis

296
Q

B-cell and T-Cell Immunodeficiencies

A
  • Severe Combined Immunodeficiency
  • Ataxia-Telangiectasia
  • Hyper-IgM Syndrome
  • Wiskott-Aldrich Syndrome
297
Q

B-cell and T-Cell Immunodeficiencies:

several types including defective IL-2R gamma chain (most common, X-linked recessive) and adenosine deaminase deficiency (autosomal recessive)

A

Severe Combined Immunodeficiency

298
Q

B-cell and T-Cell Immunodeficiencies:

  • failure to thrive
  • chronic diarrhea
  • thrush
  • recurrent viral, bacterial, fungal, and protozoal infections
A

Severe Combined Immunodeficiency

299
Q

B-cell and T-Cell Immunodeficiencies:

  • live vaccines are avoided
  • given antimicrobial prophylaxis and IVIG
  • bone marrow transplant is curative (no concern for rejection)
A

Severe Combined Immunodeficiency

300
Q

B-cell and T-Cell Immunodeficiencies:

  • ↓ T-cell receptor excision circles (TRECs)
  • absence of thymic shadow (CXR)
  • absence of germinal centers (lymph node biopsy)
  • absence of T cells (flow cytometry)
A

Severe Combined Immunodeficiency

301
Q

B-cell and T-Cell Immunodeficiencies:

  • defects in ATM gene → failure to detect DNA damage → failure to halt progression of cell cycle → mutations accumulate
  • autosomal recessive
A

Ataxia-Telangiectasia

Ataxia-Telangiectasia, ATM gene, Ataxia, spider Angiomas, IgA deficiency, ↑ AFP

302
Q

B-cell and T-Cell Immunodeficiencies:
triad of cerebellar defects (ataxia), spider angiomas
(telangiectasia) and IgA deficiency

A

Ataxia-Telangiectasia

Ataxia-Telangiectasia, ATM gene, Ataxia, spider Angiomas, IgA deficiency, ↑ AFP

303
Q

B-cell and T-Cell Immunodeficiencies:

  • ↑ AFP
  • ↓ IgA, IgG, and IgE
  • lymphopenia
  • cerebellar atrophy
  • ↑ risk of lymphoma and leukemia
A

Ataxia-Telangiectasia

Ataxia-Telangiectasia, ATM gene, Ataxia, spider Angiomas, IgA deficiency, ↑ AFP

304
Q

B-cell and T-Cell Immunodeficiencies:

  • most commonly due to defective CD40L on Th cells → class switching defect
  • X-linked recessive
A

Hyper-IgM Syndrome

305
Q

B-cell and T-Cell Immunodeficiencies:

  • severe pyogenic infections early in life
  • opportunistic infection with Pneumocystis, Cryptosporidium, and CMV
A

Hyper-IgM Syndrome

306
Q

B-cell and T-Cell Immunodeficiencies:

  • normal or ↑ IgM
  • ↓↓ IgG, IgA, IgE
  • failure to make germinal centers
A

Hyper-IgM Syndrome

307
Q

B-cell and T-Cell Immunodeficiencies:

  • mutation in WASp gene
  • leukocytes and platelets unable to reorganize actin cytoskeleton → defective antigen presentation
  • X-linked recessive
A

Wiskott-Aldrich Syndrome

308
Q

B-cell and T-Cell Immunodeficiencies:

  • thrombocytopenia
  • eczema
  • recurrent pyogenic infections
  • ↑ risk of autoimmune disease and malignancy
A

Wiskott-Aldrich Syndrome

WATER:

  • Wiskott-Aldrich
  • Thrombocytopenia
  • Eczema
  • Recurrent (pyogenic) infections
309
Q

B-cell and T-Cell Immunodeficiencies:

  • ↓ to normal IgG, IgM
  • ↑ IgE, IgA
  • fewer and smaller platelets
A

Wiskott-Aldrich Syndrome

310
Q

Phagocyte Dysfunction Immunodeficiencies

A
  • Leukocyte Adhesion Deficiency (type 1)
  • Chédiak-Higashi Syndrome
  • Chronic Granulomatous Disease
311
Q

Phagocyte Dysfunction Immunodeficiencies:

  • defect in LFA-1 integrin (CD18) protein on phagocytes
  • impaired migration and chemotaxis
  • autosomal recessive
A

Leukocyte Adhesion Deficiency (type 1)

312
Q

Phagocyte Dysfunction Immunodeficiencies:

  • recurrent skin and mucosal bacterial infections
  • absent pus
  • impaired wound healing
  • delayed (> 30 days) separation of umbilical cord
A

Leukocyte Adhesion Deficiency (type 1)

313
Q

Phagocyte Dysfunction Immunodeficiencies:

  • ↑ neutrophils in blood
  • absence of neutrophils at infection sites
A

Leukocyte Adhesion Deficiency (type 1)

314
Q

Phagocyte Dysfunction Immunodeficiencies:

  • defect in lysosomal trafficking regulator gene (LYST)
  • microtubule dysfunction in phagosome-lysosome fusion
  • autosomal recessive
A

Chédiak-Higashi Syndrome

315
Q

Phagocyte Dysfunction Immunodeficiencies:

  • progressive neurodegeneration
  • lymphohistiocytosis
  • albinism (partial)
  • recurrent pyogenic infections by staphylococci and streptococci
  • peripheral neuropathy
A

Chédiak-Higashi Syndrome

PLAIN:

  • Progressive neurodegeneration
  • Lymphohistiocytosis
  • Albinism (partial)
  • recurrent pyogenic Infections by staphylococci and streptococci
  • peripheral Neuropathy
316
Q

Phagocyte Dysfunction Immunodeficiencies:

  • giant granules in granulocytes and platelets
  • pancytopenia
  • mild coagulation defects
A

Chédiak-Higashi Syndrome

317
Q

Phagocyte Dysfunction Immunodeficiencies:

  • defect of NADPH oxidase → ↓ reactive oxygen species (eg, superoxide) and ↓ respiratory burst in neutrophils
  • X-linked form most common
A

Chronic Granulomatous Disease

318
Q

Phagocyte Dysfunction Immunodeficiencies:
↑ susceptibility to catalase ⊕ organisms

A

Chronic Granulomatous Disease

319
Q

Phagocyte Dysfunction Immunodeficiencies:

  • abnormal Dihydrorhodamine (flow cytometry) Test (↓ green fluorescence)
  • Nitroblue Tetrazolium Dye Reduction Test (obsolete) fails to turn blue
A

Chronic Granulomatous Disease

320
Q

Bacterial Infections in Immunodeficiency:

↓ T Cells

A

Sepsis

321
Q

Bacterial Infections in Immunodeficiency:

↓ B Cells

A

Encapsulated (Please SHINE my SKiS):

  • Pseudomonas aeruginosa
  • Streptococcus pneumoniae
  • Haemophilus Influenzae type b
  • Neisseria meningitidis
  • Escherichia coli
  • Salmonella
  • Klebsiella pneumoniae
  • Group B Streptococcus
322
Q

Bacterial Infections in Immunodeficiency:

↓ Granulocytes

A
  • Staphylococcus
  • Burkholderia cepacia
  • Pseudomonas aeruginosa
  • Serratia
  • Nocardia
323
Q

Bacterial Infections in Immunodeficiency:

↓ Complement

A
  • encapsulated species with early complement deficiencies
  • Neisseria with late complement (C5–C9) deficiencies
324
Q

Viral Infections in Immunodeficiency:

↓ T Cells

A
  • CMV
  • EBV
  • JC virus
  • VZV
  • chronic infection with respiratory/GI viruses
325
Q

Viral Infections in Immunodeficiency:

↓ B Cells

A
  • enteroviral encephalitis
  • poliovirus (live vaccine contraindicated)
326
Q

Fungal/Parasitic Infections in Immunodeficiency:

↓ T Cells

A
  • Candida (local)
  • PCP
  • Cryptococcus
327
Q

Fungal/Parasitic Infections in Immunodeficiency:

↓ B Cells

A

GI giardiasis (no IgA)

328
Q

Fungal/Parasitic Infections in Immunodeficiency:

↓ Granulocytes

A
  • Candida (systemic)
  • Aspergillus
  • Mucor
329
Q

B-cell deficiencies tend to produce recurrent _____ infections, whereas T-cell deficiencies produce more _____ infections.

A

B-cell → bacterial

T-cell → fungal and viral

330
Q

Grafts:
from self

A

Autograft

331
Q

Grafts:
from identical twin or clone

A

Syngeneic Graft (Isograft)

332
Q

Grafts:

from nonidentical individual of same species

A

Allograft

333
Q

Grafts:

Xenograft

A

from different species

334
Q

Transplant Rejection:

onset within minutes

A

Hyperacute

335
Q

Transplant Rejection:

  • pre-existing recipient antibodies react to donor antigen (type II hypersensitivity reaction)
  • activate complement
A

Hyperacute

336
Q

Transplant Rejection:

  • widespread thrombosis of graft vessels → ischemia/necrosis
  • graft must be removed
A

Hyperacute

337
Q

Transplant Rejection:

onset within weeks to months

A

Acute

338
Q

Transplant Rejection:

  • Cellular: CD8+ T cells and/or CD4+ T cells activated against donor MHCs (type IV hypersensitivity reaction)
  • Humoral: similar to hyperacute, except antibodies develop after transplant
A

Acute

339
Q

Transplant Rejection:

  • vasculitis of graft vessels with dense interstitial lymphocytic infiltrate
  • prevent/reverse with immunosuppressants
A

Acute

340
Q

Transplant Rejection:

onset within months to years

A

Chronic

341
Q

Transplant Rejection:

  • CD4+ T cells respond to recipient APCs presenting donor peptides, including allogeneic MHC
  • both cellular and humoral components (type II and IV hypersensitivity reactions)
A

Chronic

342
Q

Transplant Rejection:

  • recipient T cells react and secrete cytokines → proliferation of vascular smooth muscle, parenchymal atrophy, interstitial fibrosis
  • dominated by arteriosclerosis
A

Chronic

343
Q

Transplant Rejection:

  • Bronchiolitis Obliterans (lung)
  • Atherosclerosis (heart)
  • Chronic Graft Nephropathy (kidney)
  • Vanishing Bile Duct Syndrome (liver)
A

Chronic

344
Q

Transplant Rejection:

onset varies

A

Graft-Versus-Host Disease

345
Q

Transplant Rejection:

  • grafted immunocompetent T cells proliferate in the immunocompromised host and reject host cells with “foreign” proteins → severe organ dysfunction
  • type IV hypersensitivity reaction
A

Graft-Versus-Host Disease

346
Q

Transplant Rejection:

  • maculopapular rash
  • jaundice
  • diarrhea
  • hepatosplenomegaly
  • usually in bone marrow and liver transplants (rich in lymphocytes)
  • potentially beneficial in bone marrow transplant for leukemia (graft-versus-tumor effect)
A

Graft-Versus-Host Disease

347
Q

_____ are agents that block lymphocyte activation and proliferation. Reduce acute transplant rejection by suppressing cellular immunity (used as prophylaxis). Frequently combined to achieve greater efficacy with ↓ toxicity. Chronic suppression ↑ risk of infection and malignancy.

A

Immunosuppressants

348
Q

Immunosuppressants:

  • calcineurin inhibitor
  • binds cyclophilin
  • blocks T-cell activation by preventing IL-2 transcription
A

Cyclosporine

349
Q

Immunosuppressants:

  • Psoriasis
  • Rheumatoid Arthritis
A

Cyclosporine

350
Q

Immunosuppressants:

  • nephrotoxicity
  • hypertension
  • hyperlipidemia
  • neurotoxicity
  • gingival hyperplasia
  • hirsutism
A

Cyclosporine

351
Q

Immunosuppressants:

  • calcineurin inhibitor
  • binds FK506 binding protein (FKBP)
  • blocks T-cell activation by preventing IL-2 transcription
A

Tacrolimus (FK506)

352
Q

Immunosuppressants:

  • similar to cyclosporine
  • ↑ risk of diabetes and neurotoxicity
  • no gingival hyperplasia or hirsutism
A

Tacrolimus (FK506)

353
Q

Calcineurin inhibitors are highly _____.

A

nephrotoxic

354
Q

Immunosuppressants:

  • mTOR inhibitor
  • binds FKBP
  • blocks T-cell activation and B-cell differentiation by preventing response to IL-2
A

Sirolimus (Rapamycin)

355
Q

Immunosuppressants:

  • pancytopenia
  • insulin resistance
  • hyperlipidemia
  • not nephrotoxic
A

Sirolimus (Rapamycin)

356
Q

Immunosuppressants:

  • synergistic with cyclosporine
  • used in drug-eluting stents
A

Sirolimus (Rapamycin)

357
Q

Immunosuppressants:

  • monoclonal antibody
  • blocks IL-2R
A

Basiliximab

358
Q

Immunosuppressants:

  • edema
  • hypertension
  • tremor
A

Basiliximab

359
Q

Immunosuppressants:

specifically for kidney transplant rejection prophylaxis

.

A
  • Sirolimus (Rapamycin)
  • Basiliximab
360
Q

Immunosuppressants:

  • antimetabolite precursor of 6-mercaptopurine
  • inhibits lymphocyte proliferation by blocking nucleotide synthesis
A

Azathioprine

361
Q

Immunosuppressants:

  • Rheumatoid Arthritis
  • Crohn disease
  • Glomerulonephritis
  • other autoimmune conditions
A

Azathioprine

362
Q

Immunosuppressants:

pancytopenia

A

Azathioprine

363
Q

Immunosuppressants:

  • 6-MP degraded by xanthine oxidase
  • toxicity ↑ by allopurinol
A

Azathioprine

364
Q

Immunosuppressants:

reversibly inhibits IMP dehydrogenase preventing purine synthesis of B and T cells

A

Mycophenolate Mofetil

365
Q

Immunosuppressants:

Lupus Nephritis

A

Mycophenolate Mofetil

366
Q

Immunosuppressants:

  • GI upset
  • pancytopenia
  • hypertension
  • hyperglycemia
  • less nephrotoxic and neurotoxic
A

Mycophenolate Mofetil

367
Q

Immunosuppressants:

associated with invasive CMV infection

A

Mycophenolate Mofetil

368
Q

Immunosuppressants:

  • inhibit NF-κB
  • suppress both B- and T-cell function by ↓ transcription of many cytokines
  • induce T cell apoptosis
A

Glucocorticoids

369
Q

Immunosuppressants:

  • many autoimmune and inflammatory disorders
  • adrenal insufficiency
  • asthma
  • CLL
  • non-Hodgkin lymphoma
A

Glucocorticoids

370
Q

Immunosuppressants:

  • Cushing syndrome
  • osteoporosis
  • hyperglycemia
  • diabetes
  • amenorrhea
  • adrenocortical atrophy
  • peptic ulcers
  • psychosis
  • cataracts
  • avascular necrosis (femoral head)
A

Glucocorticoids

371
Q

Immunosuppressants:

  • demargination of WBCs causes artificial leukocytosis
  • adrenal insufficiency may develop if drug is stopped abruptly after chronic use
A

Glucocorticoids

372
Q

Immunosuppression

A
373
Q

Recombinant Cytokines for Bone Marrow Stimulation

A
  • Erythropoietin
  • Colony Stimulating Factors
  • Thrombopoietin
374
Q

Recombinant Cytokines for Bone Marrow Stimulation:

  • Epoetin alfa (EPO analog)
  • used in anemias (especially in renal failure)
A

Erythropoietin

375
Q

Recombinant Cytokines for Bone Marrow Stimulation:

  • Filgrastim (G-CSF) and Sargramostim (GM-CSF)
  • used in leukopenia to recover granulocyte and monocyte counts
A

Colony Stimulating Factors

376
Q

Recombinant Cytokines for Bone Marrow Stimulation:

  • Romiplostim (TPO analog) and Eltrombopag (TPO receptor agonist)
  • used in autoimmune thrombocytopenia
A

Thrombopoietin

377
Q

Recombinant Cytokines for Immunotherapy

A
  • Interleukin-2
  • Interferon
378
Q

Recombinant Cytokines for Immunotherapy:

  • Aldesleukin
  • used in renal cell carcinoma and metastatic melanoma
A

Interleukin-2

379
Q

Recombinant Cytokines for Immunotherapy:

Interferons

A
  • IFN-α—Chronic Hepatitis C (not preferred) and B, Renal Cell Carcinoma
  • IFN-β—Multiple Sclerosis
  • IFN-γ—Chronic Granulomatous Disease
380
Q

Therapeutic Antibodies for Cancer Therapy

A
  • Alemtuzumab
  • Bevacizumab
  • Cetuximab
  • Rituximab
  • Trastuzumab
381
Q

Therapeutic Antibodies for Cancer Therapy:

  • targets CD52
  • used in CLL and MS
A

Alemtuzumab

“Alymtuzumab”—chronic lymphocytic leukemia

382
Q

Therapeutic Antibodies for Cancer Therapy:

  • targets VEGF
  • used in colorectal cancer, renal cell carcinoma, and non-small cell lung cancer
  • also used in neovascular agerelated macular degeneration, proliferative diabetic retinopathy, and macular edema
A

Bevacizumab

383
Q

Therapeutic Antibodies for Cancer Therapy:

  • targets EGFR
  • used in stage IV colorectal cancer, head and neck cancer
A

Cetuximab

384
Q

Therapeutic Antibodies for Cancer Therapy:

  • targets CD20
  • usedin B-cell non-Hodgkin lymphoma, CLL, rheumatoid arthritis, ITP, and multiple sclerosis
A

Rituximab

385
Q

Therapeutic Antibodies for Cancer Therapy:

  • targets HER2
  • used in breast cancer and gastric cancer
A

Trastuzumab

HER2—“tras2zumab”

386
Q

Therapeutic Antibodies for Autoimmune Disease Therapy

A
  • Adalimumab
  • Certolizumab
  • Golimumab
  • Infliximab
  • Daclizumab
  • Eculizumab
  • Natalizumab
  • Ustekinumab
387
Q

Therapeutic Antibodies for Autoimmune Disease Therapy:

  • targets soluble TNF-α
  • used inIBD, rheumatoid arthritis, ankylosing spondylitis, and psoriasis
A
  • Adalimumab
  • Certolizumab
  • Golimumab
  • Infliximab
388
Q

Therapeutic Antibodies for Autoimmune Disease Therapy:

  • targets CD25 (part of IL-2 receptor)
  • used in relapsing multiple sclerosis
A

Daclizumab

389
Q

Therapeutic Antibodies for Autoimmune Disease Therapy:

  • targets complement protein C5
  • used in paroxysmal nocturnal hemoglobinuria
A

Eculizumab

390
Q

Therapeutic Antibodies for Autoimmune Disease Therapy:

  • targets α4-integrin—WBC adhesion
  • used in multiple sclerosis and Crohn disease
  • risk of PML (progressive multifocal leukoencephalopathy) in patients with JC virus
A

Natalizumab

391
Q

Therapeutic Antibodies for Autoimmune Disease Therapy:

  • targets IL-12/IL-23
  • used in psoriasis and psoriatic arthritis
A

Ustekinumab

392
Q

Therapeutic Antibodies:

  • targets platelet glycoproteins IIb/IIIa
  • antiplatelet agent for prevention of ischemic complications in patients undergoing percutaneous coronary intervention
A

Abciximab

IIb x IIIa equals “absiximab”

393
Q

Therapeutic Antibodies:

  • targets RANKL
  • used in osteoporosis
  • inhibits osteoclast maturation (mimics osteoprotegerin)
A

Denosumab

Denosumab affects osteoclasts

394
Q

Therapeutic Antibodies:

  • targets digoxin
  • antidote for digoxin toxicity
A

Digoxin immune Fab

395
Q

Therapeutic Antibodies:

  • targets IgE
  • used in refractory allergic asthma
  • prevents IgE binding to FcεRI
A

Omalizumab

396
Q

Therapeutic Antibodies:

  • targets RSV F protein
  • used as RSV prophylaxis for high-risk infants
A

Palivizumab

PaliVIzumab—VIrus